0
Intra-Cellular Therapies Inc Banner Image

Intra-Cellular Therapies Inc

  • Ticker ITCI
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Intra-Cellular Therapies Inc Logo Image
  • 51-200 Employees
  • Based in New York City, New York
Intra-Cellular Therapies, Inc., a biopharmaceutical company, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders within the central nervous system (CNS). Its lead drug candidate is ITI-007, which is in phase III clinical development for the treatment of schizophrenia, behavioral disturbances in dementia, bipolar disorder, depressionMore, and other neuropsychiatric and neurological disorders.
Intra-Cellular Therapies Inc

Most Recent Annual Report

Intra-Cellular Therapies Inc MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Intra-Cellular Therapies Inc has reached its limit for free report views.

Older/Archived Annual Reports